Israeli Startup FertilAI Gains Momentum with $4.5M Funding

Rohi Hourvitz, FertilAI CEO

Israeli fertility tech startup FertilAI has raised $4.5 million in seed funding, co-led by Longevity Venture Partners and Redseed, with additional support from angel investors.

FertilAI’s flagship Fertilane platform leverages AI to optimize fertility treatments, integrating with clinic EMRs to improve patient outcomes. The platform is currently used by over 50 physicians for more than 20,000 patients globally, enhancing clinical workflows and streamlining communication between doctors and patients.

The funding will enable FertilAI to expand its market presence, invest in R&D, and enhance its mobile app, which supports patients throughout their fertility journey. CEO Rohi Hourvitz emphasized the company’s mission to make fertility treatments quicker and more affordable, aiming to reduce the emotional and financial toll on patients.

Source: Femtech Insider